BEXIMCO PHARMAGDR (Germany) Market Value

R2WA Stock  EUR 0.41  0.00  0.00%   
BEXIMCO PHARMAGDR's market value is the price at which a share of BEXIMCO PHARMAGDR trades on a public exchange. It measures the collective expectations of BEXIMCO PHARMAGDR REGS investors about its performance. BEXIMCO PHARMAGDR is trading at 0.41 as of the 26th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.41.
With this module, you can estimate the performance of a buy and hold strategy of BEXIMCO PHARMAGDR REGS and determine expected loss or profit from investing in BEXIMCO PHARMAGDR over a given investment horizon. Check out BEXIMCO PHARMAGDR Correlation, BEXIMCO PHARMAGDR Volatility and BEXIMCO PHARMAGDR Alpha and Beta module to complement your research on BEXIMCO PHARMAGDR.
Symbol

Please note, there is a significant difference between BEXIMCO PHARMAGDR's value and its price as these two are different measures arrived at by different means. Investors typically determine if BEXIMCO PHARMAGDR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BEXIMCO PHARMAGDR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BEXIMCO PHARMAGDR 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BEXIMCO PHARMAGDR's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BEXIMCO PHARMAGDR.
0.00
12/02/2023
No Change 0.00  0.0 
In 1 year and 25 days
12/26/2024
0.00
If you would invest  0.00  in BEXIMCO PHARMAGDR on December 2, 2023 and sell it all today you would earn a total of 0.00 from holding BEXIMCO PHARMAGDR REGS or generate 0.0% return on investment in BEXIMCO PHARMAGDR over 390 days. BEXIMCO PHARMAGDR is related to or competes with Merck KGaA, Haleon PLC, LIVZON PHARMAC, SIMCERE PHARMAC, CanSino Biologics, Evotec SE, and Dermapharm Holding. Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmace... More

BEXIMCO PHARMAGDR Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BEXIMCO PHARMAGDR's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BEXIMCO PHARMAGDR REGS upside and downside potential and time the market with a certain degree of confidence.

BEXIMCO PHARMAGDR Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for BEXIMCO PHARMAGDR's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BEXIMCO PHARMAGDR's standard deviation. In reality, there are many statistical measures that can use BEXIMCO PHARMAGDR historical prices to predict the future BEXIMCO PHARMAGDR's volatility.
Hype
Prediction
LowEstimatedHigh
0.020.414.79
Details
Intrinsic
Valuation
LowRealHigh
0.020.334.71
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BEXIMCO PHARMAGDR. Your research has to be compared to or analyzed against BEXIMCO PHARMAGDR's peers to derive any actionable benefits. When done correctly, BEXIMCO PHARMAGDR's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BEXIMCO PHARMAGDR REGS.

BEXIMCO PHARMAGDR REGS Backtested Returns

BEXIMCO PHARMAGDR appears to be out of control, given 3 months investment horizon. BEXIMCO PHARMAGDR REGS secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22% return per unit of volatility over the last 3 months. By reviewing BEXIMCO PHARMAGDR's technical indicators, you can evaluate if the expected return of 0.94% is justified by implied risk. Please makes use of BEXIMCO PHARMAGDR's risk adjusted performance of 0.1998, and Mean Deviation of 2.76 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BEXIMCO PHARMAGDR holds a performance score of 16. The firm shows a Beta (market volatility) of 0.0292, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BEXIMCO PHARMAGDR's returns are expected to increase less than the market. However, during the bear market, the loss of holding BEXIMCO PHARMAGDR is expected to be smaller as well. Please check BEXIMCO PHARMAGDR's maximum drawdown, potential upside, semi variance, as well as the relationship between the value at risk and downside variance , to make a quick decision on whether BEXIMCO PHARMAGDR's price patterns will revert.

Auto-correlation

    
  -0.15  

Insignificant reverse predictability

BEXIMCO PHARMAGDR REGS has insignificant reverse predictability. Overlapping area represents the amount of predictability between BEXIMCO PHARMAGDR time series from 2nd of December 2023 to 14th of June 2024 and 14th of June 2024 to 26th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BEXIMCO PHARMAGDR REGS price movement. The serial correlation of -0.15 indicates that less than 15.0% of current BEXIMCO PHARMAGDR price fluctuation can be explain by its past prices.
Correlation Coefficient-0.15
Spearman Rank Test-0.15
Residual Average0.0
Price Variance0.0

BEXIMCO PHARMAGDR REGS lagged returns against current returns

Autocorrelation, which is BEXIMCO PHARMAGDR stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BEXIMCO PHARMAGDR's stock expected returns. We can calculate the autocorrelation of BEXIMCO PHARMAGDR returns to help us make a trade decision. For example, suppose you find that BEXIMCO PHARMAGDR has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

BEXIMCO PHARMAGDR regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BEXIMCO PHARMAGDR stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BEXIMCO PHARMAGDR stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BEXIMCO PHARMAGDR stock over time.
   Current vs Lagged Prices   
       Timeline  

BEXIMCO PHARMAGDR Lagged Returns

When evaluating BEXIMCO PHARMAGDR's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BEXIMCO PHARMAGDR stock have on its future price. BEXIMCO PHARMAGDR autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BEXIMCO PHARMAGDR autocorrelation shows the relationship between BEXIMCO PHARMAGDR stock current value and its past values and can show if there is a momentum factor associated with investing in BEXIMCO PHARMAGDR REGS.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in BEXIMCO Stock

BEXIMCO PHARMAGDR financial ratios help investors to determine whether BEXIMCO Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BEXIMCO with respect to the benefits of owning BEXIMCO PHARMAGDR security.